Search

everythinglearnresearchcommunity

for

Search:↓

Adding cells to fat grafts improves hair regrowth in early baldness, but effects lessen over time.

Some alopecia treatments might help treat COVID-19, but more research is needed.

Cooling the scalp may prevent hair loss from chemotherapy, hair often grows back after treatment, and nail issues usually improve after stopping the drug.

Increasing Treg cells in the skin does not cure hair loss from alopecia areata in mice.

Betamethasone is more effective than Tacrolimus and soft paraffin for hair regrowth in patchy alopecia areata.

The review highlights the importance of stem cells in hair health and suggests new treatment strategies for hair loss conditions.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

JAK inhibitors help hair regrowth in alopecia areata but have a high risk of side effects.

Microsponges delivery system is a safe, versatile method for controlled drug release in various treatments.

Prostaglandins may contribute to male hair loss; targeting them could help treat it.

Hormone imbalances from endocrine diseases can cause various skin conditions that help diagnose and treat these diseases early.

The document recommends a team-based approach and personalized care for managing diabetes in teenagers.

Tofacitinib treatment significantly improved a patient's psoriasis, psoriatic arthritis, and alopecia universalis.

Intralesional triamcinolone acetonide effectively treats alopecia areata, as shown by significant improvements in hair regrowth and dermoscopic indicators.

Steroid hormones are crucial for body functions and have various medical uses, but their misuse can lead to dependence.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

People with alopecia areata often have lower vitamin D levels than healthy people.

The book details skin conditions in older adults, their link to mental health, cancer treatment importance, hair loss remedies, and managing autoimmune and itchy skin.

Chemotherapy often causes hair loss, which usually grows back within 3 to 6 months, but there's no effective treatment to prevent it.

Stopping forehead irritation and using hydrocortisone helped a man's skin, Martinique has lower melanoma rates, a man had an allergy to a specific antifungal, another had unexplained cysts, certain drugs can cause skin reactions without always being interrelated, a link between Fanconi anemia and a skin condition was suggested, high levels of a certain protein may play a role in a type of psoriasis, and there's a need to study the connection between scalp pain and hair loss.

Biologics for severe asthma have known side effects, but some new risks need more study.

Apremilast shows promise for several skin conditions but needs more research.

A new mutation in the TMEM173 gene and a risk allele in IFIH1 cause a unique set of immune-related symptoms.

Treating alopecia areata is difficult due to limited approved treatments, but new therapies like JAK inhibitors show promise.

Men with a certain type of hair loss often use facial moisturizers, and a specific antibiotic treatment may help another hair condition.

Some drugs have gained approval for new uses, while others like tricyclic antidepressants and aspirin show promise but aren't yet approved for these uses.

No FDA-approved treatments for chemotherapy-induced hair loss existed in 2006; more research was needed.

Surface-modified nanostructured lipid carriers can improve hair growth treatments.

Tissue-derived extracellular vesicles are crucial for cancer diagnosis, prognosis, and treatment.

Alopecia areata patients have higher levels of certain immune receptors, suggesting new treatment possibilities.